SCHEMBL6903209

SCHEMBL6903209

Cc1ccc(-c2cc(-c3ccc(C)cc3)n(-c3ccccc3S(N)(=O)=O)n2)cc1.NS(=O)(=O)c1ccccc1-n1nc(-c2ccccc2)cc1-c1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.61
PTGS2 P35354 7/20 0.52
PTGS1 P23219 1/20 0.49
EGFR P00533 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
PPP1CA P62136 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
STAT1 P42224 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 1/20 0.42
NQO2 P16083 1/20 0.41
NPY5R Q15761 2/20 0.41
MMP2 P08253 1/20 0.40
MAPK9 P45984 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8422298 0.98 CYP2C9 (0.57) CYP2C9PTGS2PTGS1EGFRSMN1; SMN2
SCHEMBL8424076 0.98 CYP2C9 (0.57) CYP2C9PTGS2PTGS1EGFRSMN1; SMN2
SCHEMBL8733829 0.94 PTGS2 (0.54) CYP2C9PTGS2PTGS1EGFRSMN1; SMN2
SCHEMBL8421778 0.92 PTGS2 (0.56) CYP2C9PTGS2PTGS1SMN1; SMN2NPC1
SCHEMBL8420750 0.92 CYP2C9 (0.63) CYP2C9PTGS2PTGS1EGFRSMN1; SMN2
SCHEMBL7054592 0.91 PTGS2 (0.63) CYP2C9PTGS2PTGS1EGFRNPY5R
SCHEMBL8423752 0.90 CYP2C9 (0.49) CYP2C9PTGS2PTGS1EGFRSMN1; SMN2
SCHEMBL8422283 0.90 CYP2C9 (0.49) CYP2C9PTGS2PTGS1EGFRSMN1; SMN2
SCHEMBL8421509 0.90 PTGS2 (0.50) CYP2C9PTGS2PTGS1MAPK9
SCHEMBL8422286 0.88 PTGS2 (0.52) CYP2C9PTGS2PTGS1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1443967-A1 CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION Novartis AG (CH) 2004-08-11 EP disclosed
WO-2003039599-A1 CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION NOVARTIS AG (CH) 2003-05-15 WO disclosed